The Magazine for Sleep Professionals
Friday, November 13, 2026
The American Thoracic Society led 10 medical professional organizations in filing an amicus brief last week regarding the FDA’s failure to apply pre-market review to new tobacco products. The brief was submitted in support of the American Academy of Pediatrics and its co-plaintiffs and outlines the compelling data indicating that the FDA’s failure to act […]
Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Efficacy […]
Statement of American Lung Association National President and CEO Harold P. Wimmer in response to the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report “Tobacco Product Use Among Middle and High School Students—United States, 2011–2017,” released on June 6, 2018. “For the fourth straight year, the […]
Tobacco is the leading underlying single cause of death worldwide. In 2016, tobacco use caused over 7.1 million deaths mostly related to lung and heart disease, cancer, and stroke. Every year, on May 31, people and organizations mark World No Tobacco Day, by highlighting the health and other risks associated with […]
All in for CF Scholarship Program Doubles to Help 80 Recipients Pursue Higher Education Vertex Pharmaceuticals Incorporated announced the recipients of scholarships as part of its second All in for CF Scholarship program. Each of the 80 scholarship recipients will be awarded $5,000 for the 2018-2019 academic year. The Vertex […]
Electromed, Inc. recently announced the results of a longitudinal outcome-based study published in Respiratory Therapy: The Journal of Pulmonary Technique. The longitudinal study shows that high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduces bronchiectasis-related exacerbations including the need for antibiotics, emergency department visits, and […]
You may already know the clinical benefits of home NIV, but now discover the significant cost savings this new approach could bring to your organization. Emerging evidence has reinforced the use of home-based noninvasive ventilation (NIV) to treat patients with chronic hypercapnic COPD. This new methodology was proven in the […]
Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD GlaxoSmithKline plc and Innoviva, Inc. today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol ‘FF/UMEC/VI’), which means Trelegy Ellipta can now be used […]
Researchers from the American College of Chest Physicians conducted the Delivery Makes a Difference (DMaD) project to obtain a better understanding of health care provider and patient perspectives about the role of inhalation delivery devices in COPD. This study also examined the nature of both patient and physician understanding and the educational […]
The Mount Sinai – National Jewish Health Respiratory Institute marked the official opening of its second location on Monday, April 16, 2018, with a ribbon-cutting ceremony. The new practice, on the second floor of Mount Sinai Union Square, the Mount Sinai Health System’s comprehensive ambulatory care center at 10 Union […]
